Onivyde Prices, Coupons and Patient Assistance Programs
Onivyde (irinotecan liposomal) is a member of the miscellaneous antineoplastics drug class and is commonly used for Pancreatic Cancer.
This Onivyde price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Onivyde intravenous dispersion (4.3 mg/mL) is around $1,868 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
|10 milliliters||$186.79 – $205.27||$1,867.86 – $2,052.65|
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Onivyde Coupons and Rebates
Onivyde offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Onivyde
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Ipsen Cares Patient Assistance Program
- Must have no prescription coverage for needed medication
- Not disclosed
- US residency requirements are not specified.
- This program also provides copay assistance.
- Onivyde (irinotecan liposome) Injection
Provider: Patient Access Network Foundation (PAN)
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Onivyde (irinotecan liposome)